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Research
Chronic exposure to arsenic (As) contami­
nated drinking water is an international envi­
ronmental health problem (World Health 
Organization 1999). Once ingested, inor­
ganic As (InAs) is metabolized through a 
series of reduction and oxidative methylation 
reactions to form monomethylarsonic acid 
(MMA) and dimethylarsinic acid (DMA) 
(Kitchin 2001). Human ingestion experi­
ments performed by Buchet et al. (1981) 
indicated that As biotransformation follows 
first­order rate constants and that urinary As 
metabolites (UAs) have a half­life ranging 
from 39 to 59 hr. When individuals are at 
steady state, approximately 60% of the total 
ingested dose is excreted in the urine daily. 
Despite its short half­life, total urinary As 
(TUA) is commonly used as a biomarker of 
exposure and is positively correlated with As 
concentrations in drinking water in chroni­
cally exposed populations (Calderon et al. 
1999; Hopenhayn­Rich et al. 1996).
In addition to TUA, the percentage of 
each urinary As species is used as a biomarker 
of As metabolism. Population­based studies 
reveal considerable interindividual variabil­
ity in urinary As levels, with urine containing 
10–30% InAs, 10–20% MMA, and 60–70% 
DMA (Calderon et al. 1999; Hopenhayn­Rich 
et al. 1996). Understanding the factors that 
contribute to this observed interindividual 
variability in UAs is of growing interest because 
epidemiologic studies suggest that an individu­
al’s ability to metabolize InAs is a risk factor 
for As­related toxicity. For instance, studies in 
Mexico, Taiwan, and Bangladesh have shown 
that individuals who have a higher propor­
tion of InAs and MMA and lower DMA in 
urine have an increased risk of As­induced 
skin lesions (McCarty et al. 2007), skin cancer 
(Chen et al. 2003a; Hsueh et al. 1997; Yu et al. 
2000), and bladder cancer (Chen et al. 2003b; 
Steinmaus et al. 2006).
However, diseases associated with chronic 
As exposure have long latency periods, and it is 
unclear how stable UAs are within an individ­
ual over a long time period. To date, only two 
studies have examined intraindividual vari­
ability in UAs. Concha et al. (2002) analyzed 
UAs from 15 women chronically exposed 
to As contaminated drinking water in Chile 
and observed no significant daily intraindi­
vidual variability in the relative proportion 
or concentration of UAs over a 5­day period. 
Steinmaus et al. (2005) examined intraindivid­
ual variability in UAs in 81 individuals with a 
history of moderate to high As exposures who 
participated in a case–control study of bladder 
cancer in the United States and found that the 
relative proportions of UAs were fairly stable 
within individuals over an average interval of 
258 days. However, the observation periods 
for these studies were relatively short given 
the long latency for As­related diseases such as 
cancer. Also, Steinmaus et al. (2005) included 
participants with bladder cancer, who may 
have altered As methylation capacity.
Therefore, we conducted a 4­year pro­
spective repeated­measures biomonitoring 
study in Bangladesh to evaluate inter­ and 
intraindividual variability in UAs over a long 
time period. We recruited individuals resid­
ing in an As endemic region of Bangladesh 
who do not exhibit any dermal symptom of 
As toxicity. Our primary aim was to examine 
inter­ and intraindividual sources of variabil­
ity in UAs expressed as concentrations and as 
proportions of the TUA in an adult popula­
tion. A secondary aim was to conduct sen­
sitivity and specificity analyses to determine 
how well a single urine sample predicted an 
individual’s urinary As profile and As expo­
sure. This analysis presents the first 2 years 
of urinary As biomonitoring measurements, 
reflecting currently available data.
Materials and Methods
Study design and participant selection. We 
recruited participants through a series of com­
munity meetings held in Pabna, Bangladesh. 
Individuals were eligible for this study if they 
were long­term residents of Pabna, obtained 
their drinking water from a private tube well, 
and received primary health care from the 
Pabna Community Clinic, an affiliate of 
Dhaka Community Hospital, and if several 
members within each household were willing 
to participate. The primary rationale for mul­
tiple persons per household was to facilitate 
sample collection in rural areas.
During the initial visit in September 2001, 
a behavioral and demographic questionnaire 
was administered and blood, urine, toenail, 
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and water samples were collected. Researchers 
then visited participants at their homes every 
3 months for 4 years to collect urine, toenail, 
and water samples. In this analysis, we used 
data collected from April 2002 through March 
2004, representing eight sampling collection 
periods and reflecting currently available data. 
Beginning in the fourth sampling period, 
urine and drinking water was collected from 
each participant for 3 consecutive days dur­
ing each sampling period to capture potential 
short­term variability.
Overall, we enrolled 50 households (n = 
248 participants) in this study. Residents in 
two households (n = 13) moved out of the 
study area before April 2002 to seek employ­
ment in Dhaka. Residents from one household 
(n = 3) were diagnosed with As­induced skin 
lesions; we did not include them in this analysis 
because of the possibility that individuals exhib­
iting symptoms of chronic As toxicity may 
have altered As metabolism, and we wanted to 
examine As methylation in a more generaliz­
able population. Of the remaining participants, 
we excluded 29 children younger than 15 years 
because As metabolism may be different in 
children compared with adults (Concha et al. 
1998). Another four subjects diagnosed with 
diabetes were also excluded because they may 
have altered kidney function that could influ­
ence As excretion. Subsequently, in this analy­
sis we used data from 195 participants residing 
in 47 households.
The institutional review boards at 
Harvard School of Public Health and Dhaka 
Community Hospital approved the pro­
tocol for this study. Informed consent was 
obtainedfrom all adult participants before par­
ticipation and parental consent was obtained 
for all participants younger than 18 years.
Water sample collection and analysis. We 
collected drinking water samples from the 
tube well identified by the household mem­
bers as their primary source of drinking water. 
Tube wells were purged by pumping the well 
for several minutes before 50 mL of water was 
collected in an acid­washed polypropylene 
tube (BD Falcon, BD Bioscience, Bedford, 
MA, USA). Samples were preserved with 
reagent­grade HNO3 (Merck, Damstadt, 
Germany) to pH < 2, shipped to the Harvard 
laboratory, and kept at room temperature 
until analysis. We quantified total InAs by 
inductively coupled plasma–mass spectrometry 
using U.S. Environmental Protection Agency 
method 200.8 (Environmental Laboratory 
Services, North Syracuse, NY, USA). Analysis 
was validated using PlasmaCAL multielement 
QC standard #1 solution (SCP Science, Baíe 
Dúrfé, Quebec, Canada). The average percent 
recovery for InAs was 96.0 ± 2.9%. The limit 
of detection (LOD) for this method was 1 µg 
As/L. We assigned samples below the LOD a 
value of 0.5 µg As/L.
Urine sample collection and analysis. 
Participants were visited in their homes the 
day before urine samples were scheduled to 
be collected, provided with sterile urine col­
lection containers (VWR International, West 
Chester, PA, USA), and instructed to collect a 
first­void urine sample. Technicians collected 
the urine samples in the morning, placed 
them on ice, and transported them to Pabna 
Community Clinic, where they were trans­
ferred into 15mL polyethylene tubes (BD 
Falcon) and immediately frozen at –20°C. All 
samples were processed within several hours 
of collection. Samples were then shipped on 
dry ice to Dhaka, re­packaged with more 
dry ice, and then shipped overnight to the 
environmental chemistry laboratory of Taipei 
Medical University for analysis.
Frozen urine samples were thawed at room 
temperature, dispersed by ultrasonic waves, 
and filtered through a Sep­Pak C18 column 
to remove protein (Mallinckrodt Baker Inc., 
Phillipsburg, NJ, USA). We separated arsen­
ite (As3), arsenate (As5), MMA, and DMA 
by high­performance liquid chromatography 
(Waters 501; Waters Associates, Milford, MA, 
USA) using a Nucleosil 10u SB 100A column 
(Phenomenex, Torrance, CA, USA). Individual 
species using hydride­generated atomic absorp­
tion spectrometry (Flow Injection Analysis 
System 400AA 100; Perkin­Elmer, Waltham, 
MA, USA) as described by Hsueh et al. (1998). 
InAs was defined as the sum of As3 and As5. 
We calculated the relative proportion of each 
As species (%InAs, %MMA, and %DMA) by 
dividing the concentration of each species by 
the TUA concentration (As3 + As5 + MMA 
+ DMA). This analytical approach eliminates 
interference from arsenobetanine and arseno­
choline, which are non­toxic organic As   species 
found in seafood.
The average LOD, determined by 115 
method blanks run on separate days, for 
As3, As5, MMA, and DMA were 0.04 µg/L, 
0.06 µg/L, 0.05 µg/L, and 0.06 µg/L, respec­
tively. Quality control procedures included 
spiked samples, where a known amount of 
As3, As5, MMA, and DMA standard reagent 
was added to one sample within each batch. 
The average percent recovery for 348 spiked 
samples for As3, As5, MMA, and DMA were 
98.9 ± 6.5%, 100 ± 6.5%, 99.9 ± 6.4%, and 
100.1 ± 6.5%, respectively. Replicates of stan­
dard solutions were also analyzed during each 
laboratory day, and all were ± 5% for each 
As metabolite. Specifically, the percent dif­
ference for As3, As5, MMA, and DMA were 
–1.0 ± 3.5%, 0 ± 3.9%, –0.3 ± 3.4%, and 
–1.3 ± 3.4%. We measured urinary creatinine 
using the kinetic Jaffe method with a Hitachi 
7170S autoanalyzer (Tokyo, Japan). Although 
at least one UAs was detectable in all of the 
2,971 urine samples included in this analysis, 
46 (1.6%), 264 (8.8%), and 5 (0.2%) samples 
were below the LOD for InAs, MMA, and 
DMA, respectively.
Statistical analysis. The actual values of all 
UAs, including those below the LOD, were 
used in all analyses. All urinary As outcomes 
were positively skewed and transformed using 
a base­10 logarithm to achieve a more sym­
metric distribution.
The data structure was complex, with each 
subject having up to 18 repeated measures clus­
tered on 3 consecutive days within eight sam­
pling periods. Also, participants were clustered 
within households. We used hierarchical mixed 
models (SAS PROC MIXED; SAS Institute 
Inc., Cary, NC, USA) to assess covariate effects, 
while accounting for the correlation associ­
ated with these clusters by including random 
effects for subject and household as described 
by Singer (1998). We explored the inclusion of 
additional random effects for sampling period 
but found that the models tended to become 
unstable, and instead accounted for sampling 
periods through the inclusion of fixed effect 
indicators. This modeling approach allowed 
us to investigate sources of variance by appor­
tioning it into household (variability among 
47 households), subject (variability among 195 
subjects), and residual variance (unexplained 
variability within a subject) for each urinary 
As outcome. In a simpler setting with just one 
source of clustering, for example, repeated 
meas  urements on subjects, the intraclass corre­
lation coefficient (ICC) would be used to assess 
reliability and variability of repeated measures 
over time because the ICC simply corresponds 
to the ratio of the between­subject variance to 
the total variance. In our setting, we calculated 
the percentages of variance attributed to house­
hold, between subjects, and within subjects, 
which are analogous to an ICC with values 
ranging from 0 to 1. Values near 1 indicate high 
reliability and low intraindividual variability, 
whereas values near 0 indicate poor reliability 
and high intraindividual variability. We re­ran 
models allowing the variance components to 
differ according to various factors (e.g., sex, As 
exposure, smoking status, total water intake, 
and families that switched tube wells during the 
study) to examine the contribution of these fac­
tors on the observed variance.
To determine how well a single urine 
sample predicted categorical UAs level (i.e., 
tertiles), we calculated geometric mean values 
for each UAs (“true”) and compared them 
with tertiles constructed from a single day, the 
average of 2 days within consecutive quarters, 
the average of 3 days in consecutive quarters, 
and the average of 3 consecutive days within 
a quarter (“predicted”). The amount of agree­
ment between the “true” and the “predicted” 
in the highest tertile (sensitivity) and the low­
est two tertiles (specificity) were used to evalu­
ate potential misclassification from different 
sampling strategies.Urinary arsenic metabolites
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We used mixed­effects models to evalu­
ate the association between each urinary As 
outcome and the following fixed effects: log10 
creatinine (mg/dL), log10 drinking water As 
(µg/L), sex, age, body mass index (BMI), 
smoking (currently smokes cigarettes vs. does 
not currently smoke cigarettes), betel nut (cur­
rently chews betel nut vs. does not currently 
chew betel nut), Ramadan (sample collected 
during days of fasting vs. sample collected 
during the rest of the year), season (mon­
soon months, 1 June through 30 September; 
warm months, 1 March through 31 May; 
and cold months, 1 October through the end 
of February), and day (1, 2, or 3 within sam­
pling period). All continuous variables were 
centered at their mean. Each model included 
the nested random­effects variance structure 
described above. Geometric means for each 
UAs were provided for the fixed effects in the 
mixed model to facilitate interpretability.
We evaluated analytical robustness by 
repeating each analysis and i) excluding 
extreme outliers, including four InAs, four 
MMA, and two DMA samples that had values 
more than three standard deviations above or 
below the mean, and ii) excluding observations 
in the top and bottom 10% of the observed 
distribution. All analyses were performed using 
SAS, version 9.1 (SAS Institute Inc.).
Results
Of the 195 individuals from 47 households, 
94% initially provided a urine sample. This 
participation rate declined to 74% after 
2 years. Of the available participants, six 
never provided a urine sample, although they 
participated in other aspects of the biomon­
itoring study. No participant requested to 
be withdrawn from the study, and samples 
that were not collected were most likely due 
to individuals being absent from the home 
during scheduled collection visits. In addi­
tion, 29 urine samples were not analyzed for 
all UAs. Thus, we included a total of 2,971 
urine samples in this analysis, reflecting con­
tributions from 195 participants residing in 
47 households. Of these samples, 33%, 27%, 
and 40% were collected in monsoon, summer 
months, and winter months, respectively.
Table 1 presents the general characteristics 
of this study population. Table 2 presents the 
distributions of drinking water As levels and 
UAs for each sampling period. We measured 
at least one UAs in all samples, although we 
observed considerable variation in UAs with 
MMA being least prevalent. Overall, 33% 
of the drinking water samples exceeded the 
Bangladesh drinking water standard of 50 
µg As/L, and the majority of the participants 
(61.7%) were exposed to As in their drinking 
water, although approximately one­third of the 
drinking water samples had no detectable level 
of As. All participants were informed of the 
As levels in their tube well, and six households 
(n = 25) installed a new tube well during the 
course of the study after being told that their 
current tube well exceeded the Bangladesh 
drinking water standard.
We estimated the proportions of the 
observed total variance attributed to household 
and subject for all UAs (Table 3). When UAs 
were expressed as a percentage of the TUA, 
variability within subjects, between subjects, 
and between households explained 83–84%, 
12–15%, and 1–3% of the observed total vari­
ance, respectively. We defined generalization of 
the ICCs as the sum of the between­household 
and between­subject variances, divided by the 
total variance. These ICCs were poor (%InAs, 
0.16; %MMA, 0.16; %DMA, 0.17), indicat­
ing that the percentage of each urinary As spe­
cies was not stable within an individual over 
the 2­year period. However, when UAs were 
expressed as concentrations rather than per­
centages, variability within subjects, between 
subjects, and between households explained 
51–65%, 9–11%, and 26–40% of the observed 
total variance, respectively. The reduction of 
within­subject variability associated with using 
the concentration of each UAs increased ICCs 
to 0.41, 0.35, 0.47, and 0.49 for InAs, MMA, 
DMA, and TUA. This indicated that the con­
centration of each UAs was moderately stable 
Table 1. Population characteristics of 195 adults.
Characteristic  Percent  Mean ± SD  Range
Age (years)    33.4 ± 13  15–77
BMI    20.6 ± 3.5  13–30
Male  42.3
Current smoker  18.3
Chews betel nut  26.3
Table 2. The distribution of UAs, the percent of each urinary As species, and tube well As concentrations 
among 195 participants.
  Percentile
Parameter  GM  Minimum  10th  25th  50th  75th  90th  95th  Maximum
TW As (µg/L)  8.8  ND  0.5  0.7  12.5  96.7  160.4  327.0  567.7
TUA (µg/L)  32.3  4.3  13.9  20.6  30.2  45.9  72.9  135.6  293.0
InAs (µg/L)  3.0  0.8  1.6  2.2  3.8  6.0  10.6  17.4  51.1
Percent InAs  11.1  5.5  8.5  10.5  12.6  15.2  18.0  19.8  35.7
MMA (µg/L)  2.1  ND  1.1  1.6  2.6  4.6  8.0  15.1  50.9
Percent MMA  7.4  ND  5.0  6.5  8.5  11.3  14.0  16.6  24.4
DMA (µg/L)  20.4  3.3  10.3  16.3  22.8  36.7  54.2  103.1  200.1
Percent DMA  76.6  5.3  68.8  74.4  78.8  81.6  85.0  86.0  88.4
Abbreviations: GM, geometric mean; ND, samples less than the LOD; TW, tube well
Table 3. The proportion of the observed variance attributed to between households, between subjects, 
and within subjects for all 195 participants, including and excluding the 25 participants who had a new 
tube well installed during the 2-year observation period.
  All observations (n = 195)  No. switched wells (n = 170)
  Estimatea  Percent of total  ICC  Estimatea  Percent of total  ICC
Log TUA (µg/L)
  Between household  68.9  40  —  71.2  41  —
  Between subject  16.6  10  —  15.9  9  —
  Within subject  87.9  51  0.49  86.8  50  0.50
Log InAs (µg/L)
  Between household  76.5  30  —  78.2  31  —
  Between subject  28.9  11  —  26.9  11  —
  Within subject  150.0  59  0.41  149.5  59  0.41
Log %InAs
  Between household  0.9  1  —  0.3  0  —
  Between subject  12.9  15  —  13.5  15  —
  Within subject  74.0  84  0.16  75.1  84  0.16
Log MMA (µg/L)
  Between household  94.9  26  —  99.8  28  —
  Between subject  30.8  9  —  28.1  8  —
  Within subject  234.2  65  0.35  224.4  64  0.36
Log %MMA
  Between household  7.8  5  —  7.8  5  —
  Between subject  18.5  12  —  18.1  12  —
  Within subject  133.2  84  0.16  126.2  83  0.17
Log DMA (µg/L)
  Between household  65.2  37  —  67.1  38  —
  Between subject  17.1  10  —  16.8  10  —
  Within subject  93.9  53  0.47  92.4  52  0.48
Log %DMA
  Between household  0.2  3  —  0.1  2  —
  Between subject  1.0  13  —  0.9  13  —
  Within subject  5.9  83  0.17  5.8  85  0.15
Variance estimates were multipiled by 1,000 to aid interpretability.Kile et al.
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within the individual over the 2­year observa­
tion period. Excluding the 25 individuals who 
installed new tube wells, removing extreme 
outliers, or restricting the analysis to the 10th 
to 90th percentile of the UAs distribution did 
not change these results.
The proportion of variance models were 
stratified by sex, smoking, and exposure to 
As­contaminated water to examine how the 
variability in UAs differed among these catego­
ries (Table 4). For example, males and females 
exhibited similar inter­ and intraindividual 
variability in all urinary outcomes except at 
the household level, where household affili­
ation explained more of the total observed 
variability for males. The effect of smoking on 
the variability of UAs was examined only in 
men because no woman reported smoking in 
this population. Males who reported smok­
ing at least 10 cigarettes per week explained 
little to no observed interindividual variabil­
ity in methylated UAs MMA (0–2%) and 
DMA (0–6%) but slightly increased the intra­
individual variability in all UAs compared 
with individuals who did not report smoking. 
Exposure to As­contaminated water (expressed 
as tertiles) was also associated with increased 
variability with increased tertile of exposure, 
but the intraindividual variance was always 
greatest in the lowest exposure tertile.
The effect of several factors on mean UAs 
were examined using multivariate linear mixed­
effects models (Table 5). For continuous 
variables, we observed a positive significant 
association between As­contaminated drink­
ing water and higher InAs, MMA, DMA, 
and TUA. Increased creatinine concentra­
tions had the largest effect on all UAs, with 
increasing creatinine concentrations associated 
with increasing InAs, MMA, %MMA, DMA, 
%DMA, and TUA, although increasing crea­
tinine concentrations were inversely associated 
with %InAs. Increasing age in years was associ­
ated with decreased MMA but increased DMA. 
BMI was included in the models as a quadratic 
term, which displayed an inverted U­shaped 
relationship with MMA, with increasing BMI 
associated with increased MMA and body mass 
squared associated with decreased MMA.
We also examined several categorical 
variables for their effect on mean UAs. We 
observed that, on average, males had higher 
MMA but lower DMA and TUA compared 
with females. Individuals who reported chew­
ing betel nuts had higher concentrations of 
MMA and %MMA compared with individuals 
who did not report chewing betel nuts. Samples 
collected during Ramadan (a month of fasting 
during daylight hours) had higher urinary As 
levels for all outcomes compared with samples 
collected at other times of the year. Also, indi­
viduals who reported that they smoked had 
lower concentrations of DMA compared with 
nonsmokers. When the effect of smoking was 
examined in males only, smoking was associated 
with higher InAs compared with not smoking, 
although this association did not reach statisti­
cal significance. However, when we expressed 
As metabolites as a percentage of TUA, the 
%InAs was higher and %DMA was lower in 
males who reported smoking compared with 
males who did not report smoking.
The season in which the sample was col­
lected also influenced all UAs. Compared with 
samples collected in the monsoon months 
(June–September), samples collected in cooler 
months (October–February) were associ­
ated with the lower InAs, MMA, DMA, and 
TUA. Samples collected in the warmer months 
(March–May) also had lower InAs, MMA, 
DMA, and TUA compared with samples col­
lected in the monsoon months. This resulted in 
lower %InAs and %MMA but higher %DMA 
during cooler months, but we observed an 
opposite effect during warmer months. We also 
observed day­to­day differences in mean UAs. 
Compared with day 3, InAs was higher on day 
1 and day 2. DMA concentrations were highest 
on day 1 and decreased on day 2, although this 
trend did not reach statistical significance. TUA 
also showed a similar trend with the highest 
TUA concentrations on day 1 and lower con­
centrations on day 2 compared with day 3.
Table 6 presents the sensitivity and speci­
ficity of different sampling strategies. The 
proportion of participants that truly had the 
highest 2­year average UAs levels (top 33%) 
that would be identified as such using a single 
urine sample anytime throughout the 2­year 
observation period (i.e., sensitivity) was 0.76, 
0.76, 0.84, and 0.85 for InAs, MMA, DMA, 
and TUA, respectively. The proportions of 
participants that truly had the lowest UAs 
levels (lower 66%) that were classified cor­
rectly (i.e., specificity) were 0.74, 0.78, 0.79, 
and 0.79 for InAs, MMA, DMA, and TUA, 
respectively. This indicated that a single urine 
sample adequately classified an individual’s uri­
nary As profile, although both sensitivity and 
specificity improved with multiple sample col­
lection. Because TUA is commonly used as a 
biomarker of exposure, we examined how well 
it predicted high (top 33%) and low (bottom 
66%) tube well As concentrations. Although 
highly specific, TUA was only moderately 
sensitive at accurately characterizing drinking 
water exposures. Removing the 25 participants 
from the six households that installed a new 
tube well during the course of the study did 
not substantially influence the sensitivity or 
specificity estimates (data not shown).
Discussion
Although we observed that urinary As con­
centrations were moderately reproducible 
within this population over a 2­year period, 
the percentage of individual UAs that are used 
to evaluate As methylation capacity were not. 
This differs somewhat from the conclusions 
of Concha et al. (2002) and Steinmaus et al. 
Table 4. Percentage of total variance attributed to between-household, between-subject, and within-sub-
ject variance, estimated by stratifying models by sex, smoking (yes = currently smokes, no = never/former 
smoker), and tube well As exposure tertiles.
  Sex  Smoking  Tube well As (µg/L)
  Female  Male  Yes  No  Low  Medium  High
Log total As (µg/L) 
  Between household  34.7  41.2  40.8  38.5  9.8  31.1  37.9
  Between subject  13.1  9.6  8.3  17.9  13.5  15.6  9.4
  Within subject  52.2  49.2  50.9  43.6  76.6  53.3  52.7
Log InAs (µg/L) 
  Between household  27.1  34.4  26.8  37.2  6.1  26.2  30.9
  Between subject  10.9  9.5  12.2  13.5  16.2  13.8  9.7
  Within subject  62.0  56.1  61.1  49.4  77.6  60.0  59.4
Log %InAs 
  Between household  1.6  4.6  0.0  13.1  1.7  0.6  3.7
  Between subject  10.7  13.5  11.4  7.3  11.9  17.0  17.2
  Within subject  87.7  82.0  88.6  79.6  86.3  82.4  79.1
Log MMA (µg/L) 
  Between household  19.2  34.4  38.8  34.5  4.4  7.5  16.2
  Between subject  9.1  5.8  1.8  10.1  10.1  6.5  9.4
  Within subject  71.7  59.8  59.4  55.4  85.6  86.0  74.4
Log %MMA 
  Between household  2.1  11.5  18.1  9.5  4.2  3.7  8.1
  Between subject  7.8  7.4  0.0  10.3  6.2  13.0  24.5
  Within subject  90.1  81.2  81.9  80.3  89.7  83.3  67.4
Log DMA (µg/L) 
  Between household  32.6  37.7  37.0  35.8  8.3  23.1  10.8
  Between subject  13.9  9.3  5.9  18.7  12.8  10.3  10.2
  Within subject  53.5  53.0  57.1  45.5  78.9  66.7  79.0
Log %DMA 
  Between household  0.6  6.9  8.7  3.6  3.1  0.3  4.7
  Between subject  7.9  12.4  0.0  28.7  16.7  15.2  13.8
  Within subject  91.5  80.6  91.3  67.7  80.3  84.5  81.5
Models examining smoking were restricted to males only.Urinary arsenic metabolites
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(2005), who both reported that the percent­
age of UAs were relatively stable within indi­
viduals over a 5­day and 258­day interval. For 
instance, Steinmaus et al. (2005) reported ICCs 
of 0.45, 0.46, and 0.49 for %InAs, %MMA, 
and %DMA, respectively. Although these ICCs 
are similar to what we reported for the con­
centration of UAs, they are much higher than 
what we observed for the percentage of UAs. 
However, the different results of these stud­
ies could be explained by different environ­
mental and behavioral factors unique to each 
population. For instance, in Bangladesh, par­
ticipants rely exclusively on local water sources 
for all their drinking water. This differs from 
the United States, where more beverage options 
are available. In addition, As exposures in the 
United States may be more constant than in 
Bangladesh, where As mitigation programs 
encourage families to avoid As­contaminated 
water by using water filters or sharing a neigh­
bor’s tube well that is considered safe (Hanchett 
et al. 2002). Also, dietary As exposures may 
be more significant and more variable in 
Bangladesh than in the United States, particu­
larly for individuals with low tube well As expo­
sures (Kile et al. 2007; Smith et al. 2006). Also, 
As metabolism may be sensitive to time­varying 
events that were not captured in our study but 
play a more important role in Bangladesh, such 
as folate intake.
It is also likely that the low intraindividual 
correlations with respect to %InAs, %MMA, 
and %DMA were a function of the inherent 
instability of ratios with small denominators as 
seen in approximately half of this population 
Table 5. Geometric means for all urinary As outcomes stratified by sex, tube well (TW) As tertiles, Ramadan, age, BMI, BMI2, smoking status, betel nut use, 
  average creatinine, season, and day.
    InAs  MMA  DMA  TUA 
      GM    GM      GM    GM      GM    GM      GM 
Variable  No.  (µg/L)   p-Value  (%)  p-Value  No.  (µg/L)  p-Value  (%)  p-Value  No.  (µg/L)  p-Value  (%)  p-Value  No.  (µg/L)  p-Value
Overall  2,914  3.0  —  10.9  —  2,739  2.2  —  7.4  —  2,936  20.9  —  76.9  —  2,939  27.7  —
Sex
  Male  1,234  3.5    12.0    1,178  2.9    9.3    1,239  21.6    73.9    1,239  29.2
  Female  1,680  2.7  0.9  10.2  0.006  1,561  1.7  0.04  6.2  < 0.001  1,697  20.4  0.001  79.1  0.001  1,700  25.7  0.01
TW As (µg/L)
  < 1  1,111  1.8    10.6    1,022  1.3    7.0    1,124  13.1    77.8    1,126  16.7
  1–50  846  3.0    10.7    793  2.1    7.0    852  21.4    78.2    852  27.4
  > 50  957  5.5  < 0.001  11.5  0.03  924  4.1  < 0.001  8.3  0.87  960  35.4  < 0.001  74.6  0.007  961  47.2  < 0.001
Ramadan
  Yes  289  4.0    10.3    273  2.7    6.6    289  30.2    78.3    289  38.5
  No  2,625  2.9  0.008  11.0  0.93  2,466  2.1  0.001  7.5  0.03  2,647  20.1  0.001  76.7  0.92  2,650  26.1  0.004
Age (years)
  15–25  1,058  3.4    12.1    992  2.2    7.3    1,064  21.1    75.7    1,065  27.7
  26–35  788  3.3    11.4    750  2.1    6.8    794  22.2    77.6    794  28.6
  36–45  602  2.5    10.2    559  2.1    7.9    604  19.4    77.0    606  24.9
  ≥ 46  466  2.3  < 0.002  8.7  < 0.001  438  2.3  0.94  8.0  0.46  474  20.5  0.01  78.3  0.001  474  26.2  0.11
BMIa
  < 18  520  2.8    11.1    496  2.3    8.7    525  19.2    75.8    526  25.2
  18–25  1,966  3.1    11.0    1,845  2.2    7.2    1,979  21.1    76.7    1,987  27.4
  > 25  428  2.9  0.05  10.1  0.36  398  2.0  0.34  6.6  0.99  432  22.2  0.14  78.9  0.40  432  28.1  0.08
Smokerb
  Yes  532  4.0    13.5    508  3.1    9.8    532  21.3    71.3    532  21.3
  No  2,382  2.8  0.13  10.4  < 0.001  2,231  2.0  0.49  6.9  0.11  2,404  20.8  0.02  78.1  0.004  2,407  26.5  0.15
Betel nutb
  Yes  763  2.7    9.9    722  2.5    8.5    773  20.6    77.2    775  26.4
  No  2,151  3.1  0.48  11.3  0.24  2,017  2.1  0.01  7.0  0.001  2,163  21.0  0.31  76.7  0.10  2,164  27.3  0.48
Log creatinine (mg/dL)
  Low  954  1.6    11.1    845  1.1    7.1    971  10.6    75.7    974  13.9
  Medium  994  3.1    10.8    944  2.2    7.4    999  21.8    77.2    999  28.2
  High  966  5.5  < 0.001  10.8  < 0.001  950  4.0  < 0.001  7.7  < 0.001  966  39.6  < 0.001  77.7  < 0.001  966  51.0  < 0.001
Seasonb
  Winter  1,120  2.3  < 0.001  10.0  0.13  1,027  1.5  < 0.001  5.8  < 0.001  1,130  18.1  < 0.001  79.5  0.007  1,132  22.6  < 0.001
  Summer  819  3.2  0.09  2.2  0.001  775  2.5  0.04  8.9  0.14  824  19.5  < 0.001  73.9  0.003  825  26.3  < 0.001
  Monsoon  975  3.8  —  10.9  —  937  3.0  —  8.3  —  982  26.1  —  76.4  —  982  34.2  —
Dayb
  1c  1,356  3.3  < 0.001  11.4  < 0.001  1,260  2.3  0.94  7.3  0.17  1,371  22.0  0.09  76.9  0.40  1,372  28.5  0.03
  2  800  2.8  0.10  10.9  0.01  758  2.0  0.18  7.3  0.28  805  19.4  0.06  76.1  0.02  805  25.5  0.46
  3  758  2.7  —  10.0  —  721  2.2  —  7.6  —  760  20.6  —  77.6  —  762  26.3  —
GM, geometric mean. p-Values are from the test for fixed effects using log-transformed data in mixed models with nested random effects for family, subject, and quarter.
aBMI modeled as quadratic BMI2 (p-values: %InAs, 0.34; InAs, 0.05; %MMA, 0.86; MMA, 0.27; %DMA, 0.37; DMA, 0.14; TUA, 0.08). bTest of two groups (males vs. females; Ramadan vs. 
not Ramadan; smoker vs. nonsmoker; betel nut vs. not betel nut; winter vs. monsoon; summer vs. monsoon; day 1 vs. day 3; day 2 vs. day 3). cFor sampling periods 1–3, samples were col-
lected only on day 1; for sampling periods 4–8, samples collected on 3 consecutive days.
Table 6. Sensitivity for predicting participants with highest overall mean InAs, MMA, DMA, TUA (top 33%) and specificity for predicting participants with lowest 
(bottom 66%) overall mean InAs, MMA, DMA, and TUA. 
  Log InAs  Log MMA  Log DMA  Log TUA  Log TUA to TW
Sampling scenario  Sensitivity  Specificity  Sensitivity  Specificity  Sensitivity  Specificity  Sensitivity  Specificity  Sensitivity  Specificity
One sample  0.76  0.74  0.76  0.78  0.84  0.79  0.85  0.79  0.81  0.56
Two samples (3 months apart)  0.83  0.86  0.81  0.78  0.90  0.79  0.90  0.86  0.84  0.54
Three samples (each 3 months apart)  0.86  0.89  0.88  0.82  0.91  0.87  0.91  0.85  0.83  0.51
Three samples (3 consecutive days)  0.83  0.86  0.82  0.78  0.91  0.76  0.90  0.81  0.87  0.57
TW, log10 tube well As (µg/L). We also examined TUA sensitivity and specificty for predicting highest (top 33%) and lowest (bottom 66%) overall drinking water As exposure. Kile et al.
460  v o l u m e  117 | n u m b e r 3 | March 2009  •  Environmental Health Perspectives
who had low As exposure. For these indi­
viduals, other sources of As exposure such as 
diet could be an important contributor to the 
observed variability. We found evidence sup­
porting this conclusion when we stratified the 
observed variability by tube well As exposure. 
Specifically, individuals in the lowest tertile 
of exposure had the greatest intraindividual 
variability compared with higher tertiles, yet 
the magnitude of the estimates for the within­
subject variance were similar across exposure 
tertiles. This indicated that the variability 
associated with the individual was relatively 
constant and independent of tube well As 
exposure. Other nondrinking water sources 
of As exposure would also explain the low 
specificity of TUA for correctly identifying 
individuals with low tube well As exposure.
We further examined variance in UAs by 
stratifying models on known characteristics 
that have been suggested to influence UAs. 
Parsing the variance in this fashion demon­
strated that unknown factors within subjects 
remained the largest source of variance for all 
UAs, although some interesting patterns did 
emerge. For instance, compared with females, 
males had less intraindividual and less inter­
individual variability but more between­
household variability with the strongest effect 
observed for MMA. This between­household 
difference could be a function of genetic fac­
tors because traditional Bangladeshi house­
holds are organized along paternal bloodlines 
where males remain in the household after 
marriage. Thus, males from the same house­
hold were more highly related (e.g., offspring 
or sibling) compared with females, who were 
either the maternal blood relative or an unre­
lated spouse. It was also interesting to note 
that smoking explained a portion of the inter­
individual variability in InAs but little to none 
of the interindividual variability in methy­
lated As metabolites MMA and DMA. This 
suggested that smoking interfered with As 
methylation capacity. We also examined the 
variance stratified by season (data not shown). 
Although the proportion of variance between 
individuals varied by season, we observed no 
difference at the household level, which sug­
gested that unknown behavioral or dietary 
differences that varied with season contrib­
uted to the observed interindividual variance.
The results from the mixed­effects models 
on the average UAs concentrations showed 
that sex, tube well As exposure, Ramadan, age, 
BMI, smoking, chewing betel nuts, urinary 
creatinine, season, and day influenced mean 
UAs. Many of these effects have been reported 
in other studies. For instance, several studies 
show that males excrete more InAs and less 
DMA compared with females and that DMA 
excretion increases with age (Hopenhayn­Rich 
et al. 1996; Vahter 1999). Thus, it would seem 
that urinary As concentrations and the percent­
age of UAs have different utilities as biomark­
ers with concentrations reflecting exposure and 
percentages reflecting susceptibility. Through 
careful examination of the differences between 
urinary As concentrations and the percentage 
of UAs, it is possible to distinguish between 
associations that could be driven by exposure 
and associations driven by biological responses. 
For instance, the concentrations of all UAs 
increased with tube well As levels, but only 
the percentage of InAs and MMA—and not 
DMA—increased with As exposure. This sug­
gested the possibility that As metabolism was 
slowed or possibly saturated as As exposure 
increased. In the case of smoking, we found 
no significant association with urinary As 
concentrations, but individuals who reported 
smoking excreted a higher percentage of InAs 
and a lower percentage of DMA compared 
with individuals who did not report smoking. 
This suggested that smoking interfered with As 
methylation but was not necessarily a source of 
As exposure. Because the percentages of UAs 
were sensitive to changes in both the numera­
tor and denominator, it was useful to examine 
how factors influenced both the relative per­
centage and the concentration of urinary As to 
gain greater insight into As metabolism.
In conclusion, this is the longest prospective 
biomonitoring study of As exposure published 
to date. We observed that urinary As ratios were 
poorly reproducible within the individual over 
a 2­year observation period but that urinary As 
concentrations were fairly reproducible. Because 
intraindividual variability can contribute to mis­
classification, using urinary As concentrations 
would reduce this source of measurement error 
and potentially improve statistical precision. 
Also, by reporting both urinary As concentra­
tions and the percentage of UAs, it was pos­
sible to examine how risk factors influenced As 
methylation. Finally, unknown time­varying 
factors appeared to be the largest contributor 
to the observed inter­ and intraindividual vari­
ability in As metabolism. Considering that an 
individual’s ability to metabolize As appears to 
influence susceptibility to chronic As exposure, 
more research is needed to identify those behav­
ioral and environmental factors that influence 
As metabolism.
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